Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Briacell Therapeutics Corp T.BCT

Alternate Symbol(s):  BCTX | BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.


TSX:BCT - Post by User

Bullboard Posts
Comment by ChupacabraBuenoon Mar 25, 2019 11:16am
71 Views
Post# 29531570

RE:Tooez1

RE:Tooez1
Pugsrock2 wrote: Been reading your posts. You seem quite knowledgeable and altruistic in your information. I am guite new to this game. Wondering if you can help me out?. You said there are a number of companies doing the same thing but I am not very savvy on Google so maybe you could give me a few names so I could do some comparative research. Also you believe this company is not an investment. Unfortunately I thought BCT could be a good investment so wondering what brought you into this one as a shareholder albeit not for much longer? Perhaps you intially had the same misconceived ideas that I have currently. Looking forward to you thoughts


BCT's presentations available on their website provide a list of other companies engaged in immunotherapy. They do this at least in part to highlight their own comparatively atractive valuation & to point out that their off-the-shelf approach is a positive differentiator for them.

Immunotherapy is arguably THE hot top in oncology, so it's no surprise that there are numerous companies working on it.

I'd like to learn more about these companies too. And I appreciate tooez1's perspectives.

But IMO our friend tooez1 may be losing patience with BCT just as things are starting to really come together for them/us. I would not be surprised to find that this latest PP turns out to be the last chance for investors to pick up shares cheap (full disclosure: I bought some for $0.105 last week to add to an existing position).

-GLTA


Bullboard Posts